For an 80-year-old patient with acute intracranial hemorrhage and severe agitation, is it appropriate to prescribe intramuscular olanzapine (Zyprexa) 5 mg or intramuscular haloperidol (Haldol) 5 mg?

Neither IM olanzapine nor IM haloperidol should be used as first-line agents for severe agitation in an 80-year-old patient with acute intracranial hemorrhage.

Critical Safety Concerns in Geriatric Patients

The 2025 JAGS geriatric emergency guidelines explicitly warn against routine use of parenteral antipsychotics in older adults with severe agitation, citing "high rates of serious adverse events" even with one or two acute doses 1. This is particularly concerning in your 80-year-old patient with intracranial hemorrhage, where any adverse event could be catastrophic.

Why These Medications Are Problematic

For IM Olanzapine (Zyprexa) 5 mg:

• The FDA label establishes efficacy at 5-10 mg doses for agitation 22, but this data comes from younger psychiatric populations (schizophrenia, bipolar disorder)
• No safety or efficacy data exists for geriatric patients with acute neurological injury
• The 2025 JAGS guidelines found concerningly high adverse event rates with parenteral antipsychotics in older adults 1
• Risk of hypotension, oversedation, and metabolic effects are amplified in elderly patients

For IM Haloperidol 5 mg:

• The 2018 Critical Care Medicine guidelines recommend against routine haloperidol use for delirium treatment in critically ill adults 3
• Research shows haloperidol has slower time to sedation (median 23 minutes) compared to alternatives 4
• Carries risk of extrapyramidal symptoms, dystonia, QT prolongation, and cardiac arrest (documented in studies) 45
• In geriatric populations, haloperidol performed poorly with only 25% achieving sedation within 20 minutes in one study 6

Recommended Approach

Step 1: Exhaust Non-Pharmacologic Interventions First

The 2025 JAGS guidelines mandate attempting these before any medication 1:

• Sensory reduction (minimize light, noise)
• Reorientation and person-centered communication
• Caregiver/family engagement at bedside
• Address reversible causes: pain, hypoxia, urinary retention, constipation

Step 2: If Medication Absolutely Necessary

Oral medications should be offered before parenteral routes 1. The 2025 JAGS data shows:

• Oral quetiapine has the most favorable safety profile in older adults with agitation 1
• Oral formulations (tablets or liquid) are less coercive and safer than IM 1

Step 3: If Parenteral Route Unavoidable

The evidence hierarchy for geriatric agitation shows:

• Ziprasidone IM had zero adverse events (0/17 patients) in the JAGS review 1
• Avoid benzodiazepines entirely - midazolam showed excessive risk in older adults with higher redosing rates and paradoxical agitation 1
• Never co-administer antipsychotic + benzodiazepine in elderly patients 1

Critical Pitfalls to Avoid

1. Do not use standard adult dosing - geriatric patients require dose reduction
2. Intracranial hemorrhage is a relative contraindication - any sedation-related hypotension or respiratory depression could worsen cerebral perfusion
3. Monitor for oversedation - the 2025 JAGS guidelines found this was a major adverse event in older adults 1
4. Haloperidol's cardiac risks are unacceptable in a critically ill 80-year-old 4

Special Considerations for Intracranial Hemorrhage

Your patient's acute ICH adds another layer of complexity:

• Blood pressure management is critical - antipsychotics can cause hypotension
• Oversedation impairs neurological monitoring
• Respiratory depression risks increased intracranial pressure
• The underlying brain injury may be causing the agitation (treat the cause, not just the symptom)

If you must use a parenteral antipsychotic despite these warnings, consider ziprasidone IM at reduced geriatric dosing with continuous cardiorespiratory monitoring, but recognize this is off-label and high-risk in this population.